DY vs MRNA · P/E 44, rev $3.97B vs rev $145.0M
Dycom Industries Inc (DY) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Dycom Industries Inc (DY) is a engineering & construction company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported DY revenue for 2026-08-01 was $3.97B. Net income was $206.9M. DY currently screens at market cap $14.00B and trailing P/E 44.5.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
DY currently screens at market cap $14.00B and trailing P/E 44.5. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the DY and MRNA stock pages for the full models.
Not investment advice.